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Abstract
Background: Literature on the disease profile of prisoners that differentiates by age and gender remains sparse.
This study aimed to describe the health of correctional inmates in terms of substance abuse problems and mental
and somatic health conditions, and compare it by gender and age.
Methods: This study examined cross-sectional data from the Canton of Vaud in Switzerland on the health conditions
of detainees who were in prison on January 1, 2011 or entered prison in 2011. Health conditions validated by physician
examination were reported using the International Classification of Diseases (ICD) version 10. The analyses were
descriptive by groups of prisoners: the entire sample (All), Men, Older adults and Women.
Results: A total of 1,664 individuals were included in the analysis. Men comprised 91.5 % of the sample and had a
mean age of 33 years. The other 8.5 % were women and had an average age of 39. Older adults (i.e., age 50 and older)
represented 7 % of the total sample. Overall, 80 % of inmates were non-Swiss citizens, but the proportion of
Swiss prisoners was higher among the older adults (51 %) and women (29 %). Overall, 41 % of inmates self-reported
substance abuse problems. Of those, 27 % were being treated by psychiatrists for behavioral disorders related to
substance abuse. Chronic infectious diseases were found in 9 % of the prison population. In addition, 27 % of
detainees suffered from serious mental health conditions. Gender and age had an influence on the disease
profile of this sample: compared to the entire prison population, the older inmates were less likely to misuse
illegal drugs and to suffer from communicable infections but exhibited more problems with alcohol and a higher
burden of chronic health conditions. Female prisoners were more disposed to mental health problems (including
drug abuse) and infectious diseases. In terms of chronic diseases, women suffered from the same conditions as
men, but the diseases were more prevalent in women.
Conclusion: It is important to understand the different disease profiles of prisoners by gender and age, as it
helps identify the needs of different groups and tailor age-and gender-specific interventions.
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Background
The prison population is increasing worldwide [1], and
it is widely accepted that prison inmates have poor
health due to accumulated vulnerability factors such as
traumatic life experiences, lack of a social network and
low socioeconomic background [2]. Studies have shown
that poly-morbidity among prisoners is high, with
substance abuse, mental illnesses and infectious dis-
eases as the most common health problems [3–5].
Substance abuse and dependence are common prob-
lems encountered among the prison population [6, 7].
It is not uncommon to observe 1 out of 3 or even 1 out
of 2 inmates with drug abuse or dependence [8].
Smoking and alcohol problems are also common in
prisons [9–11]. The widely-known negative health
outcomes of tobacco use and secondhand smoke are
highly problematic, and even more so in confined
environments [12, 13].
Psychotic and personality disorders, including anti-
social personality problems and major depression, are
often identified among incarcerated people [14]. A re-
cent literature review conducted in 24 countries revealed
a constant prevalence of psychotic disorders over time
[15]. Although they have conflicting figures, empirical
studies on psychiatric and psychological disorders
among young prisoners have confirmed the high preva-
lence of mental health problems [16].
With regard to prisoners’ physical health, there have
been extensive investigations into infectious diseases
such as human immunodeficiency virus and acquired
immunodeficiency syndrome (HIV), hepatitis B and C
and tuberculosis [5, 17]. Although there is still some un-
certainty about the actual number of people living be-
hind bars with these communicable illnesses, studies
have consistently reported prevalence rates exceeding
those observed in the community [18, 19]. In high in-
come countries, the prevalence of HIV and tuberculosis
has been found to be about 10 to15 times higher than in
the civilian population [3, 20]. Moreover, the extent of
infectious-disease transmission within prisons remains
unknown; it is, however, not marginal [18, 21].
By comparison, non-infectious diseases have received
less attention [19], and studies describing specific
chronic conditions and their frequencies among of-
fenders are limited. Available data highlight higher rates
of diabetes, hypertension and asthma among inmates
when compared to the general population in the USA
[22], whereas in Switzerland the prevalence of these con-
ditions among the prison population has been in line
with that of the general population [3].
Most of the abovementioned studies present health in-
formation for young male prisoners, who form the bulk
of the prison population (more than 90 % in most coun-
tries) [23]. Knowledge about the health status of special
groups is limited. However, the number of older adults
in prison is growing and is projected to increase further
[24]. The growing older prisoner population is even
viewed as a future health and economic crisis for both
criminal justice systems and societies [25]. Today, in
many countries, there is a tendency towards longer cus-
todial sentences and sentences of undetermined length
and/or life sentences, meaning that people entering
prison when they are young are likely to remain when
they are older [26]. Defining a strict threshold for when
a prisoner becomes an “older prisoner” is complicated
[27]. Prison contributes to accelerating the biological
process of aging, and time spent in prison aggravates
and increases medical problems [28]. Few papers in the
literature tackle the health issues of this still small pro-
portion of the prison population [26]. Reviews have sug-
gested that prisoners aged 55 and older have a much
higher prevalence of major diseases and functional im-
pairments and multi-morbidity than younger prisoners
[5] and non-prisoners of similar age [5, 26]. However, lit-
tle is known about the extent to which chronic and de-
generative diseases linked to aging – whose physiological
signs (in the community) include hearing, visual and
cognitive decline as well as reduced mobility –will in-
crease the healthcare needs of older prisoners [29].
Women are another minority group in prison. They
make up less than 8 % of the total prison population in
Europe by country [23]. Like older prisoners, their popu-
lation is reported to be growing. Explanations of this
growth include a combination of social and political fac-
tors [30] linked to the nature of the offences committed.
The majority of women are incarcerated for non-violent,
property or drug-related crimes, for which they generally
serve short sentences [31]. Like their male counterparts,
or even more so, incarcerated women are disproportion-
ately affected by multiple health problems such as sub-
stance abuse (DAPHNE Projects data in MacDonald,
2013), HIV infection, sexually transmitted diseases and
severe mental health problems [8, 32]. Furthermore,
post-traumatic disorders, depression, self-harming be-
haviors and eating disorders are also common among fe-
male inmates [31, 32].
Limited research has been done on prisoners’ health
and disease profile (including non-infectious, chronic
diseases) that differentiates between these specific
groups. In particular, there are very few studies in which
the health problems among male, female and older pris-
oners have been estimated for the same prison setting/
area and over the same time period. And yet, better
knowledge of the epidemiological situation in prison –
particularly the extent to which health is similar or dif-
ferent among male, female and older prisoners – is a
prerequisite for evaluating prisoners’ healthcare needs and
determining how to provide appropriate and targeted
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health services. This study examines exhaustive and recent
health and demographic data on prisoners living in the
Canton of Vaud, which is a region in the French-speaking
part of Switzerland. The aim is to portray the health of
correctional inmates, including their somatic and mental
health conditions and substance abuse, and to differentiate
by gender and age.
Methods
In 2011, the prison population in Switzerland amounted
to around 6,100 inmates distributed across111 institu-
tions [33]. With about 80 prisoners per 100,000 inhabi-
tants, Switzerland has one of the lowest incarceration
rates in the world [34]. The present work reports data
from the entire prison population of the Canton of
Vaud. Approximately 1 in 10 permanent Swiss residents
lives in the Canton of Vaud. It has one semi-open prison
and 4 closed facilities for both men and women. The five
institutions receive remand prisoners and prisoners serv-
ing sentences (see Table 1). The total number of stays in
prison rose from 1,941 in 2002 to 2,610 in 2011.
The study used an exhaustive and unique dataset of
demographics and medical information for all the pris-
oners in the closed facilities in 2011. It includes pris-
oners who were already in prison on January 1, 2011
and those who entered these facilities at any time
throughout 2011. Cross-sectional data for the 2,610 in-
mate stays were individually collected by the Service of
Correctional Medicine and Psychiatry (Service de
Médecine et Psychiatrie Pénitentiaire–SMPP) affiliated
with the University Hospital of Lausanne (CHUV). After
data management, data cleaning and collapsing the mul-
tiple stays by the same individual over the 12 months
into a single stay, the final sample consisted of 2,185 in-
dividuals. The study sample was then restricted to indi-
viduals who had a routine physician examination upon
prison entry (N = 1,664). Under Swiss law, every incar-
cerated person should be seen by a general practitioner
(GP) within 7 to 21 days following his/her entry [35, 36].
There may have been individuals who refused the entry
examination. Also, time constraints such as a short stay
or transfer to another prison may not have allowed for a
meeting with a GP. Because the health information for
these prisoners (n = 521) was incomplete, their data was
removed from our analysis. All new prisoners receive a
health evaluation by a nurse within 24 h of their entry in
order to manage emergency situations and ensure con-
tinuity of care. In addition to the examinations by the
GP and nurse, 44.8 % (N = 747) of the prisoners were ex-
amined by a psychiatrist and were found as having at
least one psychiatric health conditions. The number of
prisoners examined by a psychiatrist and without psychi-
atric diagnosis is negligible. Psychiatric examination hap-
pens at the request of health professionals (GP, nurses),
penitentiary staff or the prisoners themselves. The psy-
chiatric examination may also be a compulsory part of
the prisoners’ sentence.
Thus, the information on inmates’ health conditions
came from diagnoses made by a GP for somatic prob-
lems and by a psychiatrist for mental problems. These
diagnoses relied on the prisoners’ case history, their self-
reported information and additional medical tests when
necessary. Health conditions were reported using the
International Classification of Diseases (ICD) version 10,
from which chronic diseases were selected and further
examined. ICD-10 is the standard diagnostic tool for
routine medical practice and epidemiology. It is used to
monitor the incidence and prevalence of diseases and
other health problems [37]. Moreover, using ICD-10 to
report health conditions is imperative for psychiatry,
since it is the only classification accepted for health- and
disability-insurance purposes in Switzerland. We also
used information from nurses’ consultations regarding
inmates’ substance-related problems. In such cases, two
complementary assessments for these disorders are
available: that nurse’s assessment containing the inmate’s
self-declarations, and the psychiatrist’s diagnosis.
Based on ICD-10, chronic conditions related to infec-
tions, skin problems, and the musculoskeletal, digestive,
circulatory, endocrine, respiratory and nervous systems
were sorted into groups. Additional subgroups were also
created, including back pain, hypertension, diabetes,
asthma, bronchitis, and migraines. For the purposes of
our study, 4 prisoner groups were looked at: the entire
study sample (All), men, older adults and women. Al-
though the threshold for “older” prisoners varied from
50 to 65 years depending on the study [5, 27], we chose
to define older adults as people aged 50 or older.
Statistical analysis
The analyses were descriptive for each prisoner group:
the entire sample (All), men, older adults and women.
Statistical analyses included percentages, means, and
standard deviations (SDs) or 95 % confidence intervals
(CI). We used a Chi-squared test to explore associations
between diseases and patients’ characteristics. Logistic
Table 1 The four closed facilities in the Canton of Vaud
Prison’s name Capacity Type of sentences served Gender of
inmates
Bois Mermet 100 Custody on remand Male





La Croisée 170 Remand and short custodial
sentences
Male
Plaine de l’Orbe 264 Long sentences Male
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regression models, including age and gender as adjust-
ment variables, were run to test potential origin of re-
lated diseases. Statistical analyses were performed with
STATA, the Data Analysis and Statistical software
(version 12, StataCorp).
Ethical considerations
The study was approved by the ethical commission of
the Canton of Vaud, Switzerland (Protocol No. 388/12).
Data were anonymized. As the study was retrospective
and used only anonymized and aggregated data, individ-
ual agreement was not required.
Results
Socio-demographic characteristics
A total of 1,664 individuals examined by a physician
upon entry were included in our analysis. The study
sample was similar to the whole sample (N = 2,185) in
terms of gender, age and nationality. The 521 individuals
(24 %) who were excluded had stayed an average of
16 days, suggesting that they were released or trans-
ferred before the GP examination. Men comprised
91.5 % of the study sample, and their mean age was
32.8 years (SD 10.3, range 16–82 years). Women repre-
sented 8.5 % of the sample population and had an aver-
age age of 38.8 (SD 10.3, range 16–69 years). Older
adults (aged 50+) made up 7 % of the sample (n = 136)
and averaged 57.02 years old (SD (6.07, range 50–82
years). Among the older group, 90 % were men. Other
demographic characteristics such as age group, marital
status and nationality for the 3 study groups are pro-
vided in Table 2.
From the sample population, 80 % of inmates were
non-Swiss citizens, but the proportion of Swiss detainees
was higher among the older adults (51 %) and women
(29 %). Nationalities of 99 different countries were re-
ported, with the main regions being Eastern Europe and
Africa for the full sample, Western Europe for the older
adults, and Africa and Eastern Europe for the women
(Table 2).
Eleven percent of all prisoners had entered prison
prior to 2010 (28 % of the older adults and 23 % of the
women). Most of the prison population entered prison
during the study year (62 %). Among them, 22 % had
stays of less than one month, and 73 % of less than
6 months.
Comparing the characteristics of our sample with
the prison population of Switzerland for the same
year (see Table 2), our study sample showed the same
proportion of men and women and a similar age dis-
tribution, but the Swiss nationality was less repre-
sented. There were also differences in the length of
stays: in 2011, stays lasting less than one month
amounted to 22 % in our sample compared with
more than double that nationally. On the other hand,
27 % of detainees in the Canton of Vaud had a stay
longer than 6 months, versus 20 % nationally. The
proportion of prisoners in the sample serving long
sentences was higher than in the national prison
population. This may be related to the presence of fa-
cilities for long custodial sentences in the Canton of
Vaud that are not necessarily available in all Swiss
prisons.
Disease profile of the prisoners (All)
Prisoners suffered from multiple health problems, as re-
ported in Tables 3 and 4. Overall, 41 % of inmates self-
declared substance-abuse problems, such as with illegal
drugs, pharmaceuticals or alcohol. Of that group, 27 %
were being treated by psychiatrists for behavioral disor-
ders related to psychoactive substance use (Table 3).
Psychiatric examination also revealed evidence of psychi-
atric problems other than substance abuse. The preva-
lence of personality and behavioral disorders among
inmates was 16.2 %, and 15.9 % for neurotic disorders.
Prisoners also suffered from schizophrenia, mood disor-
ders and behavioral syndromes. Overall, 35.1 % suffered
from some form of mental disorder other than substance
use.
Chronic infectious diseases were found in 9 % of the
prison population. Hepatitis C and HIV were the most
common. In terms of somatic chronic health problems,
the most frequently identified diseases were those affect-
ing the musculoskeletal system (13 %). Other problems
are detailed in Table 4. In addition, almost 1 prisoner in
2 self-reported smoking. Among all prisoners, 40 % had
at least one somatic chronic health condition.
Older adults
A lower rate of mental illness related to psychoactive
substance use and confirmed by a psychiatrist was found
among older inmates compared to prisoners under 50
(19 % vs. 27 %). Notably, compared to prisoners under
50, older adults were significantly less likely to misuse il-
legal drugs (p < 0.0001) but more likely to abuse alcohol
(p < 0.0001). Self-reported information on substance use
was 30 %–45 % higher than what was confirmed by psy-
chiatric follow-up. In all, 3.5 % of the older prisoners
had the 3 dependencies.
Data indicated that 42.6 % of the older inmates suf-
fered from at least one psychiatric disorder other than
substance use. Twenty-six percent suffered from person-
ality disorders, 13 % from neurosis, 6.6 % from schizo-
phrenia and 4 % from mood disorders.
Of the older adults, 1.5 % were found to have HIV and
3 % to have hepatitis C. There was no significant dif-
ference compared to prisoners under 50 (p = 0.35 and
p = 0.23).
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Diseases of the musculoskeletal, circulatory and re-
spiratory systems were more frequent in the group of
older adults than in the full sample. The association
between being an older adult and suffering from a
health condition was statistically significant for back
pain (p = 0.02), hypertension (p < 0.0001), bronchitis
(p = 0.002) and endocrine disorders (p < 0.0001) and
almost statistically significant for digestive problems
(p = 0.058). Overall, 60 % of older prisoners had at least
one chronic health condition (excluding mental problems).
Women
Female inmates had a higher prevalence of psychiatric
problems than the men. Behavioral disorders related to
psychoactive substance use were confirmed by a special-
ist to exist in one-third of the female detainees, signifi-
cantly higher than in the men. Female inmates were
more often found to have drug addictions (26 % vs.
17.2 %, p = 0.013). However, no gender differences were
evident for misuse of pharmaceuticals (4.2 % for women
vs. 5.3 % for men) or alcohol (10.7 % for women vs 9.4 %
Table 2 Demographic characteristics, year of entry and length of prison stay for the prison population in the Canton of Vaud and in
all of Switzerland for 2011
Prisoners in the Canton of Vaud National prison population (*) [55]
All Men Older adults Women Number of
incarcerations(N = 1,664) (N = 1,524) (N = 136) (N = 140)
Gender in % (N)
Male 91.5 (1524) 100 (1524) 89.70 (122) 0 92.0 7,988
Female 8.5 (140) 0 10.30 (14) 100 8.0 690
Age (mean, SD, range) 32.8 (10.3, [16, 82]) 31.61 (10.6, [16, 82]) 57.02 (6.07, [50, 82]) 38.8 (10.3, [16, 69]) NA
Age group as % of the total
24 and under 23.38 (389) 24.28 (370) 0 13.59 (19) 25.79 2,212
25–34 39.60 (658) 39.83 (607) 0 36.42 (51) 37.35 3,241
35–44 22.77 (380) 21.85 (333) 0 33.57 (47) 21.99 1,908
Over 44 14.24 (237) 14.04 (214) 100 16.42 (23) 15.18 1,317
Nationality in % (N)
Swiss 20.0 (332) 19.2 (292) 51.4 (70) 28.6 (40) 36.02 3,126
Non-Swiss 80.0 (1,332) 80.8 (1,232) 48.6 (66) 71.4 (100) 63.98 5,552
Eastern Europe 24.7 (411) 25.2 (385) 14.7 (20) 18.6 (26) NA
Africa 24.4 (406) 25.0 (381) 2.9 (4) 17.8 (25) NA
Western Europe 13.9 (231) 13.5 (206) 22.0 (30) 17.8 (25) NA
North Africa and Middle East 12.1 (202) 13.0 (197) 5.9 (8) 3.7 (3) NA
America 3.5 (58) 2.6 (40) 1.5 (2) 12.8 (18) NA
Asia 1.4 (24) 1.5 (23) 1.5 (2) 0.7 (1) NA
Marital status in % (N)§ (N = 1,641) (N = 1,501) (N = 135) (N = 140)
Divorced 13.5 (221) 12.2 (183) 42.9 (58) 27.1 (38) NA
Single 65.8 (1,080) 67.5 (1,014) 22.9 (31) 47.1 (66) NA
Married 19.2 (316) 19.2 (288) 28.1 (38) 20.0 (28) NA
Widowed 1.5 (24) 1.1 (16) 5.9 (8) 5.8 (8) NA
Year of entry into prison in % (N)
Before 2010 10.7 (177) 10.4 (298) 28.0 (38) 23.6 (19) NA
In 2010 27.3 (454) 27.9 (425) 24.2 (33) 20.7 (29) NA
In 2011 62.0 (1,033) 61.7 (941) 47.8 (65) 65.7 (92) NA
Length of stay in 2011 in % (N)
1 month 22.0 (366) 22.1 (338) 19.1 (26) 20.0 (28) 47.55 4,126
<3 months 54.8 (913) 55.0 (839) 47.0 (64) 52.8 (74) 67.72 5,877
< 6 months 73.1 (1,217) 72.7 (1,109) 62.5 (85) 77.1 (108) 79.47 6,896
(*) Characteristics of the national prison population refer to the number of incarcerations and not to the number of individuals
NA: Information not available
(§) This information is missing for 23 observations
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for men). In examining the self-declared substance abuse
assessments, pharmaceutical misuse was significantly
more frequently reported by women than men (16 % vs.
10 %; p = 0.024). A large proportion (40 %) of female in-
mates reported smoking.
Regarding other mental disorders, results showed that
female prisoners were more disposed to mental illnesses
than men, with the increased prevalence ranging from
25 % to 75 %. The only exception was behavioral syn-
dromes, for which the rate was slightly lower than for
men (1.5 % vs. 2 %). Moreover, there was a significant
gender difference for 3 groups of mental disorders:
mood disorders, “reaction to severe stress” and personal-
ity disorders (see Table 3).
Among the various infectious diseases, HIV and
hepatitis C infections were significantly more fre-
quent among female prisoners than male prisoners
(9.2 vs. 2.7 % p < 0.0001 for HIV and 10 % vs. 5.2 %
p = 0.002 for hepatitis C). However, less than 1 %
had hepatitis B (no gender difference found). Back
pain, hypertension, asthma and migraines were more
frequent among female than male inmates. While
back pain and hypertension didn’t show a significant
gender difference, asthma and migraines did (5 % vs.
2.3 % p =0. 03; resp. 4.2 % vs. 0.7 % p < 0.0001).
Chronic diseases related to origin in the study sample
Compared to people from Western Europe (including
Swiss people), prisoners from Africa and Eastern Europe
were less likely to suffer from substance abuse (OR 0.11
95 % CI 0.07-0.16 and OR 0.27 95 % CI 0.19-0.37), but
those from the Middle East were more likely (OR 1.71
95 % CI 1.23-2.39), particularly with pharmaceutical (OR
7.70 95 % CI 4.50-13.17) and alcohol (OR 2.04 95 % CI
1.32-3.15) dependencies. Lower prevalence rates for al-
cohol misuse were found in Eastern European (OR 0.41
95 % CI 0.25-0.69) and African inmates (OR 0.30 95 %
CI0.16-0.54) compared with Western European pris-
oners. Detainees from the Middle East had a higher bur-
den of digestive disorders (OR 2.20, 95 % CI 1.24-3.89),
prisoners from Africa more frequently reported hyper-
tension (OR 2.43, 95 % CI 1.22-4.85) than prisoners
from Western Europe, but less frequently endocrine dis-
orders (OR 0.41 95 % CI 0.16-1.04; p = 0.062).
Discussion
Using a cross-sectional, large-scale and comprehensive
dataset on prisoner health, this study portrayed the epi-
demiological situation of the prison population in the
Canton of Vaud, Switzerland. First, unlike other studies
that use prison population samples, this study analyzed
exhaustive data on prisoners in Vaud Canton over the
same time period. Second, while many studies tend to
emphasize either male prisoners or young prisoners, we
differentiated the disease profiles between groups of in-
mates (All, Men, Older adults and Women). Third, this
study provides direct comparisons between the health of
two minority inmate groups (older adults and women)
and the younger and male prisoners on four aspects of
health: substance abuse, mental health, infectious dis-
eases and chronic conditions. As such, it contributes to
the literature on the health burden among prisoners in
general, and that of older and female prisoners in
particular. Finally, this study underlines the fact that
Table 3 Mental health conditions and dependencies for the four groups
Proportion of prisoners with a mental illness (ICD 10 codes)
and psychiatric follow-up
All Men Older adults Women Chi 2
(N = 1664) (N = 1524) (N = 136) (N = 140) p-value
% 95 % CI % 95 % CI % 95 % CI % 95 % CI Sex Age
Mental illness classified as a behavioral disorder due to
psychoactive substance use (F10-F19)
26.3 24.2-28.4 25.6 23.4-27.9 19.1 12.8-26.7 32.8 25.1-41.3 NS 0.048
Drugs (F11-12-13-19) 18.0 16.1-19.9 17.2 15.4-19.2 3.7 1.2-8.4 25.7 18.7-33.8 0.013 <0.001
Pharmaceuticals (F13) 5.2 4.2-6.4 5.3 4.2-6.6 2.2 0.4-6.3 4.2 1.6-9.0 NS NS
Alcohol (F10) 9.5 8.0-11.1 9.4 8.0-11.0 16.2 10.4-23.4 10.7 6.1-17.0 NS 0.006
Schizophrenia (F 20-F29) 5.3 4.3-6.5 5.1 4.0-6.3 6.6 3.0-12.2 7.1 3.5-12.8 NS NS
Mood [affective] disorders (F30-F39) 2.2 1.6-3.1 1.7 1.1-2.4 3.7 1.2-8.4 7.8 4.0-13.6 <0.001 NS
Neurotic, stress-related and somatoform disorders
(F40-F49) = mainly reaction to severe stress, and
adjustment disorders
15.9 14.1-17.8 14.8 13.0-16.7 13.2 8.0-20.1 27.1 19.9-35.3 <0.001 NS
Behavioral syndromes associated with physiological
disturbances and physical factors (F50-F59)
1.9 1.3-2.7 1.9 1.3-2.7 0.0 0.0 1.4 0.2-5.0 NS NS
Disorders of adult personality and behavior (F60-69) 16.2 14.5-18.0 15.1 13.3-16.9 25.7 18.6-34.0 27.8 20.6-36.0 <0.001 <0.002
Mental retardation (F70-79) and other disorders (F80-99) 2.8 2.0-3.6 2.5 1.8-3.5 3.7 1.2-8.4 5.0 2.0-10.0 NS NS
Any mental disorder (excluding substance use) 35.1 32.8-37.5 33.3 31.0-35.7 42.6 34.2-51.4 55.0 46.3-63.4 <0.001 0.050
NS: not significant (at a 5 % level)
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prisoners are suffering from multiple morbidities com-
bining psychiatric and somatic disorders. Beyond these
findings, our study also made some specific and import-
ant points, which are highlighted below.
From the literature, it is evident that prisoners are at
higher risk for drug problems than those living in the
community [5, 6]. There is a notable heterogeneity
among studies, and estimated prevalence of drug abuse
varies from 10 % to 53 % in male offenders. In a Swiss
context, active use of illegal drugs was found in 40 % of
remand prisoners [3]. In our study, the two available
measures on drug problems revealed differences: 18 % of
prisoners were diagnosed with drug abuse problems in
the psychiatric follow-up, but in the entry examination
Table 4 Main chronic health conditions of the 4 groups
Proportion of prisoners with diseases
(ICD 10 codes)
All Men Older adults Women Chi 2 Prevalence data in the
general Swiss population(N = 1664) (N = 1524) (N = 136) (N = 140) P-value
% 95 % CI % 95 % CI % 95 % CI % 95 % CI Sex Age %
Infectious diseases 8.9 7.6-10.4 8.1 6.8-9.6 4.4 1.6-9.3 17.1 11.3-24.4 <0.001 NS
HIV (B20-B24-Z21) 2.7 1.9-3.6 2.1 1.1-2.9 1.5 0.1-5.2 9.0 5.0-15.3 <0.001 NS 0.3 [56]
Hepatitis B (B16 B18) 1.5 1.0-2.2 1.6 1.0-2.3 0.0 0-2.6 0.7 0.01-3.9 NS NS 0.3 [57]
Hepatitis C (B17 B18.2) 5.0 4.1-6.2 4.6 3.6-5.6 2.9 0.8-7.3 10.7 6.1-17.0 0.002 NS 0.7-1 [57]
Tuberculosis (A15 A16) 0.36. 0.13-0.78 0.4 0.08-0.7 0.0 0.0 NS NS 0.007 [56]
Tuberculosis sequelae (B90) 0.66 0.33-1.17 0.7 0.3-1.1 0.0 0.0
Diseases of the musculoskeletal
system (M10 M15 M54 M54.4)
12.8 11.2-14.5 12.8 11.1-14.5 21.3 14.7-29.2 12.8 7.8-19.5 NS 0.002
Back pain only (M54 M54.4) 9.0 7.8-10-6 9.0 7.6-10.6 14.7 9.2-21.8 10.7 6.1-17.0 NS 0.020 8.8 for 34 < age < 44; 11.9
for 55 < age < 64 [58]
Diseases of the digestive system
(K21 K25-K 26 K29 K58 K70)
7.6 6.4-9.0 7.6 6.4-9.1 11.7 6.9-18.4 7.1 3.4-12.7 NS NS
Diseases of the circulatory system
(I05-I09 I10 I20 I25 I50 I87.2)
6.5 5.4-7.8 6.3 5.2-7.7 33.0 25.2-41.6 7.8 4.0-13.62 NS <0.001
Hypertension (I10) 5.5 4.3-6.6 5.3 4.2-6.5 25.7 18.6-33.9 6.4 2.9-11.8 NS <0.001 2.2-8.1 for age < 49; 23.6
for 50 < age < 64 [59]
Skin problems (B36.0 D10-D36
L20-30 L40 L50 L70)
8.1 6.8-9.5 8.3 6.9-9.8 5.8 2.5-11.2 5.7 2.5-11 NS NS
Endocrine diseases (E66 E10-14 E78) 5.1 4.1-6.2 5.2 4.1-6.4 22.8 16.0-30.7 4.3 15.9-9.1 NS <0.001
Diabetes (E10-14) 2.1 1.5-2.9 2.1 1.5-3.0 13.23 8.0-20.1 2.1 0.4-6.1 NS <0.001 0.6-1.8 for age < 49; 5.8
for 50 < age < 64 [59]
Diseases of the respiratory system
(J30 J32 J41 J45)
5.5 4.4-6.7 5.4 4.3-6.6 9.5 5.2-15.8 6.4 3-11.9 NS 0.029
Asthma (J45) 2.3 1.7-3.2 2.1 1.4-2.9 2.9 0.8-7.3 5.0 2.0-10.0 0.030 NS 2.5 for age 30-39 yrs [60]
Bronchitis (J41) 2.1 1.5-2.9 2.2 1.5-3.1 5.9 2.5-11.2 1.4 0.1-5.0 NS 0.002
Diseases of the nervous system
(G40 G43.0)
1.4 0.9-2.0 1.1 0.6-1.8 2.2 0.4-6.3 4.2 1.5-9 0.002 NS
Migraines (G43.0) 0.7 0.3-1.2 0.4 0.1-0.8 0.7 0.1-4.0 4.2 1.5-9.0 <0.001 NS 7.7 for age < 24-9.3
for age < 44 [58]
Self-reported subs. misuse or
dependence
Drug misuse 32.2 29.6-34.5 32.0 29.6-34.3 5.9 2.5-11.2 35.0 27.1-43.5 NS <0.001 Cannabis: men 12;
women 4 15 < age < 34
[61]
Pharmaceutical misuse 10.8 9.3-12.3 10.2 8.7-11.7 4.0 1.6-9.3 16.0 10.7-23.6 0.024 0.013
Alcohol misuse 18.9 17.0-20.8 19.0 16.9-20.9 24.2 17.3-32.5 17.8 11.9-25.2 NS NS
Cigarette misuse 46.4 43.9-48.8 46.9 44.4-49.4 38.9 30.7-47.7 40.0 31.8-48.6 NS 28.2 % in 2012 [59]; 32.4
for men; 24.2 for women;
Any drug, pharmaceutical,
or alcohol misuse
40.8 38.4-43.1 40.7 38.2-43.2 29.4 21.9-37.8 42.1 33.8-50.7 NS 0.005
NS: not significant (at a 5 % level)
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conducted by nurses, 32 % of inmates self-declared be-
ing active drug users. The difference can be explained by
3 factors. The main explanation is that many detainees
declared themselves to be drug abusers even when not
addicted and without necessarily having or showing
symptoms requiring a psychiatrist examination. If such
prisoners do not explicitly seek psychiatric help to treat
their drug misuse problem, they are not seen by psychia-
trists. Also, the estimated rate from self-reports may be
overestimated. Some prisoners may report problems for
the purpose of obtaining medications/treatments that
would help them bear incarceration [21]. Finally, the
organizational constraints of incarceration may imply
that some prisoners do not have time or opportunity to
see a psychiatrist during their stay. The number of pris-
oners with a psychiatric diagnosis of substance use may
thus be underestimated, especially for men, given their
greater numbers. The heterogeneity of data on substance
abuse in prison underscores the challenge of obtaining
an accurate prevalence of drug use/misuse in the prison
population [38], especially when some prisoners hide
their dependencies to avoid sanctions [21].
Our findings indicate that the need for substance
abuse treatment is great and important for inmates. It is
also now recognized that systematically rehabilitating
prisoners with substance abuse problems often remains
an empty hope [39]. Previous therapy consisting of pro-
viding drug-free programs have now been replaced by
substitution –methadone-maintenance programs –at
least in some European countries [40]. This has been the
therapeutic approach adopted in the prisons included in
this study for several years.
Communicable diseases, such as hepatitis B and C and
HIV were found at rates between 5 and 10 times greater
than those reported in the Swiss general population
(Table 3). Our results are consistent with those in France
and Canada [20, 41, 42] and those found in the large re-
mand Swiss prison in Geneva [3]. With a rate of tuber-
culosis among the studied inmates >50 times that of
Swiss civilians, our findings confirm the public health is-
sues related to this disease. As pointed out by the WHO
(Stop TB Strategy [43]), the prison population is one of
the risk groups that needs special attention. Efforts
already implemented to improve detention conditions
(including overcrowding, hygiene conditions and nutri-
tion) should be further developed to better contain the
transmission of this disease. This is particularly relevant
in a population made up of a disproportionate number
of individuals with high risk factors for tuberculosis
(HIV, intravenous drug use, low socioeconomic back-
ground as well as geographical origin [43]).
The prevalence of common conditions such as back
pain, hypertension, diabetes and asthma among pris-
oners was in the same range as that observed in their
counterparts living outside the prison in the country
(Table 4). Compared to recent US studies, prisoners
from the Canton of Vaud tended to show lower rates of
hypertension, asthma and diabetes [8]. Moreover, com-
pared to a publication reporting health problems among
detainees in Geneva [3], our results exhibited lower rates
of skin problems, migraines and asthma, but higher rates
of back pain, diabetes and hypertension. There are sev-
eral explanations to account for these differences. First,
our study sample was older, which may explain the
higher rate of hypertension and diabetes. Second, instead
of focusing on remand prisoners, our sample included
inmates not only on remand awaiting trial, but also on
trial and serving short and long sentences. Prisoners
serving sentences have to work in prison under some-
times sub-optimal or not very ergonomic conditions,
leading to health problems such as back pain. Third and
importantly, the methodology differed in that the health
conditions of prisoners were reported according to 2 differ-
ent international classifications: International Classification
of Primary Care versus ICD-10.
Compared to the entire study population, the older
adult prisoners showed a different disease profile. First,
older prisoners did not suffer from the same type of ad-
dictions. Drug abuse was significantly less frequent
among prisoners aged 50+, whereas alcohol abuse disor-
ders were more frequent. This finding is in line with
results from Scottish prisoners where the group aged
40–64 showed a higher proportion of prisoners with al-
cohol dependence than the group aged 25–39 [9]. Add-
itionally, a recent analysis of the health profile of older
prisoners in north-west England revealed that the preva-
lence of alcohol abuse was higher than that of drug
abuse [26]. A second feature of the disease profile of the
older adults was the higher prevalence of mental disor-
ders compared to their younger counterparts. Excluding
the dependence disorders, about 40 % of older prisoners
had mental health problems. In our study, schizophrenia
was reported at 6.5 % and personality disorders at 26 %,
while the English study found rates of 5 % and 20 % re-
spectively [26]. Third, communicable infections were
significantly less frequent among older prisoners than
younger prisoners. Finally, older prisoners showed a
higher prevalence of more common chronic diseases
than their younger counterparts, and than older people
living outside the prison. Overall, these findings con-
firmed the previous results indicating that a large pro-
portion of older prisoners suffer from psychiatric
illnesses and chronic health problems [44, 45]. The dif-
ferences in disease profiles between younger and older
prisoners raise questions about the required healthcare
needs of prisoners, not only now but also in the future.
In prison, healthcare needs linked to aging have
emerged as great challenges. Addressing the delivery of
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healthcare services to older prisoners with multiple mor-
bidities as well as age-related degenerative diseases raises
inescapable issues with respect to the equivalence of care
between prison and the community [46]. Provision of
equivalent care takes on an extra dimension with the
management of cognitive impairments such as dementia
[47] and transitional end-of-life care needs [48]. Another
issue that impacts the health of older prisoners is the
structural environment of prison facilities. The prisons
were initially designed for vigorous and independent
people, and were not built to provide decent care to
people who might need assistance with basic personal
everyday life tasks and/or who may have geriatric
syndromes.
Gender also had an influence on the disease profile
among the study population. We found that substance
abuse was more often encountered in female than in
male prisoners. Our results reinforced previous findings
showing gender differences in the prevalence of drug use
disorders among prisoners [6, 8]. In Europe, previous
studies have found problematic drug use ranging from
10 % to 50 % in female prisoners [49]. Up-to-date results
based on DAPHNE Projects data and reported by
McDonald [30] revealed that 75 % of female prisoners in
Germany, and 98 % in Scotland, had addiction problems
with drugs, alcohol, prescription drugs and eating dis-
orders. We also found that female prisoners were
more likely than men to have co-existing psychiatric
disorders such as personality disorders, depression
and anxiety. This is in line with results reported in
the literature [50, 51] showing that women were also
more likely to self-harm and commit suicide than
male inmates [32]. In addition, although it was not
examined in our study due to a lack of available data,
many female prisoners might also be mothers or have
worries about children. As a result, the mental health
needs of female prisoners are complex.
Stress and anxiety associated with incarceration may
be compounded by the overcrowded conditions and vio-
lence existing in prison facilities. If overcrowding signifi-
cantly worsens the physical health of prisoners by
encouraging the spread of communicable disease, it
seems likely that overcrowding could also adversely im-
pact the mental health of prisoners [52]. Mental illness
also complicates treatment for co-morbidities, such as
HIV, which requires strict adherence to drug therapy
and careful monitoring for adverse drug interactions
[53]. Addressing the mental health needs of male and fe-
male prisoners will improve not only their quality of life
but also that of the prison staff and those without men-
tal health illnesses [54].
Compared to men, women in prison had a higher
burden of communicable diseases (almost double),
especially for HIV and hepatitis C. This is similar to
estimations from French prisons [20]. As for common
chronic diseases, the incarcerated women in the study
region suffered from the same health conditions as men
but the diseases were more prevalent in women. Add-
itionally, female prisoners have specific needs related to
reproductive health (menstruation, menopause, preg-
nancy), and such needs are often more challenging than
those of men [30, 51]. The growing number of incarcer-
ated women raises concerns about gender-specific issues
and needs in places initially designed for men.
Limitations and strengths
The aim of this study was to describe the health status
of prisoners by investigating substance abuse and mental
health and chronic health problems, including infectious
diseases. The study provides much needed knowledge
on health in prison and helps to identify prisoners’
specific healthcare needs in general as well as by age
and gender. However, our decision to focus on
chronic conditions does not allow us to provide a
complete picture of health problems since daily ill-
nesses and symptoms (injuries) were excluded. Special
focus on these more acute disorders would be inter-
esting. Errors in collecting and reporting data may
exist even if several checks were carried out to ensure
coherence. Having restricted the analysis to people
who were examined upon entry limited the underesti-
mation errors of not only infectious and communic-
able diseases, but also chronic diseases. Indeed, the
examination upon entry as a routine provides a de-
tailed medical history of the prisoners and as such
may identify symptoms leading to a precise diagnosis.
Although examination on entry might also help iden-
tify other problems that individuals arrive with and
that are associated with life experience, they may be
more difficult to categorize. Concerning whether the
data can be generalized, we analyzed the characteris-
tics of those prisoners who did not receive a phys-
ician entry visit and were removed from our results.
We found that they were similar to those included in
the study in terms of gender, nationality and marital
status. The excluded group was slightly younger
(mean age of 30 years, SD = 9.5). Their average length
of stay was 16 days. We have concluded that exclud-
ing these individuals has very little impact on the
data and does not prevent the results from being gen-
eralized. Finally, it cannot be excluded that the preva-
lence of psychiatric disorders might be slightly
underestimated since not all prisoners had the oppor-
tunity to have a psychiatric examination. This is be-
cause their stay was short or because they were
transferred to another prison in Switzerland (or they
were deported to their country of origin). However,
this was a very small proportion of the prisoners
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since specific training for both nurses and peniten-
tiary staff allows them to identify psychiatric needs ef-
ficiently. They are therefore able to set up an
examination relatively quickly. More than 95 % of
new prisoners are seen by nurses, assuring good med-
ical follow-up/management. Thus the percentage of
inmates in need of a psychiatric examination who do
not get the opportunity is very small indeed and has
little impact on the data.
Strengths of this study include the large sample size
and use of recent, exhaustive data from a prison
population. This population includes different types of
inmates, ranging from prisoners on remand awaiting
trial to prisoners serving a sentence. Thus it closely
mirrors the prison population of all of Switzerland,
thereby increasing its external validity and allowing
for extrapolation of our results.
Conclusion
This paper contributes to the knowledge on disease
profiles of incarcerated persons with a particular focus
on two minority groups– older inmates and female
inmates– on which the literature remains sparse. The
specificities of their health situations help identify prior-
ities for group-specific interventions. There is an urgent
need for research priorities and policy initiatives on
“aging and health” in the criminal justice system. Devis-
ing them will be beneficial both for the inmates and
prison health professionals, who may feel powerless
without the specific knowledge to deal with this group.
Also, it seems crucial to evaluate the extent to which the
aging prison population will be taxing on societies in
terms of financial and other resources. Programs already
in place that appropriately target female inmates should
be sustained and, where possible, reinforced. More lon-
gitudinal research investigating health trends over time
and health prior to and during detention are also
needed. Such work would allow us to determine the
changes that occur in the health profile of prisoners
upon incarceration as well as the extent to which health
of prisoners deteriorates or improves in prison, and the
factors associated with those health changes.
Abbreviations
ICD: International Classification of Disease; GP: General practitioner;
CI: Confidence interval; OR: Odds ratio; SD: Standard deviation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KM is responsible for the study design, and interpreted the data, supported
data management, conducted the statistical analysis, and drafted the
manuscript. PS performed data management and conducted the
statistical analysis. TW made substantial contributions to improve the
study design. AH participated in the initial conception of the work. PB
participated in the interpretation of the data. JBW made substantial
contributions to improve the study design. BE participated in the initial
conception of the work. BG elaborated and coordinated data collection
and participated in the interpretation of the data; he revised the
intellectual content of the manuscript. All authors gave critical contributions
to the manuscript. They also approved the final version.
Acknowledgements
The authors would like to thank staff of the Service of Correctional Medicine
and Psychiatry (SMPP) for the efforts in collecting the data.
This research was undertaken as part of a larger project funded by the Swiss
National Science Foundation (SNF) and thus the authors acknowledge the
financial support received from the SNF (CR13I1_135035/1).
Author details
1Institut universitaire de médecine sociale et préventive, Unité d’evaluation
des soins, University Hospital of Lausanne (CHUV), Route de la Corniche 10,
1010 Lausanne, Switzerland. 2Technology Assessment Unit (UET), University
Hospital of Lausanne (CHUV), Lausanne 1011, Switzerland. 3Institute for
Biomedical Ethics, Institute for Biomedical Ethics, University of Basel,
Bernoullistrasse 28, Basel 4056, Switzerland. 4Institut d’économie et
management de la santé (IEMS), HEC Lausanne and Département
d’économétrie et d’économie politique (DEEP), University of Lausanne,
Internef Building, Lausanne 1015, Switzerland. 5Vulnerable Population Center,
Department of Ambulatory Care and Community Medicine, University of
Lausanne, Lausanne 1011, Switzerland. 6Service of Correctional Medicine and
Psychiatry (SMPP), University Hospital of Lausanne (CHUV), Prilly-Lausanne
1008, Switzerland. 7Centre universitaire romand de médecine légale,
University of Geneva, Geneva, Switzerland. 8IEMS - Plateforme interfacultaire
en économie et management de la santé, University of Lausanne CH,
Internef Building, Lausanne 1015, Switzerland.
Received: 1 July 2014 Accepted: 2 September 2015
References
1. Justice M. Story of the Prison Population: 1993 – 2012 England and
Wales. 2013.
2. Rieder J, Gravier B, Bertrand D, Pasche C, Bodenmann P, Wolff H. Santé
en milieu carceral Vulnerabilité partagée entre detenus et
professionnels de la santé. Rev Med Suisse Romande. 2010;6:1462–5.
3. Wolff H, Sebo P, Haller DM, Eytan A, Niveau G, Bertrand D, et al. Health
problems among detainees in Switzerland: a study using the ICPC-2
classification. BMC Public Health. 2011;11:245.
4. Rosen DL, Hammond WP, Wohl DA, Golin CE. Disease prevalence and
use of health care among a national sample of black and white male
state prisoners. J Health Care Poor Underserved. 2012;23(1):254–72.
5. Fazel S, Baillargeon J. The health of prisoners. Lancet. 2011;377(9769):956–65.
6. Fazel S, Bains P, Doll H. Substance abuse and dependence in prisoners:
a systematic review. Addiction. 2006;101(2):181–91.
7. Wolff N, Frueh BC, Shi J, Gerardi D, Fabrikant N, Schumann BE. Trauma
exposure and mental health characteristics of incarcerated females
self-referred to specialty PTSD treatment. Psychiatr Serv. 2011;62(8):954–8.
8. Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG. Gender
differences in chronic medical, psychiatric, and substance-dependence
disorders among jail inmates. Am J Public Health. 2010;100(3):476–82.
9. Parkes T, MacAskill S, Brooks O, Jepson R, Atherton I, Doi L, et al. Prison
health needs assessment for alcohol problems. Edinburgh: NHS Health
Scotland; 2011.
10. Kissell A, Taylor PJ, Walker J, Lewis E, Hammond A, Amos T.
Disentangling alcohol-related needs among pre-trial prisoners: a
longitudinal study. Alcohol and Alcoholism. 2014;49(6):639–644.
11. Etter JF, Ritter C, Christie DH, Kunz M, Rieder JP, Humair JP, et al.
Implementation and impact of anti-smoking interventions in three prisons in
the absence of appropriate legislation. Prev Med. 2012;55(5):475–81.
12. Ritter C, Huynh CK, Etter JF, Elger BS. Exposure to tobacco smoke before
and after a partial smoking ban in prison: indoor air quality measures.
Tob Control. 2012;21(5):488–91.
13. Clarke JG, Martin RA, Stein L, Lopes CE, Mello J, Friedmann P, et al. Working
Inside for Smoking Elimination (Project W.I.S.E.) study design and rationale
to prevent return to smoking after release from a smoke free prison.
BMC Public Health. 2011;11:767.
Moschetti et al. BMC Public Health  (2015) 15:872 Page 10 of 11
14. Blaauw E, Roesch R, Kerkhof A. Mental disorders in European prison systems.
Arrangements for mentally disordered prisoners in the prison systems of 13
European countries. Int J Law Psychiatry. 2000;23(5-6):649–63.
15. Fazel S, Seewald K. Severe mental illness in 33,588 prisoners worldwide:
systematic review and meta-regression analysis. Br J Psychiatry.
2012;200(5):364–73.
16. Gisin D, Haller DM, Cerutti B, Wolff H, Bertrand D, Sebo P, et al. Mental
health of young offenders in Switzerland: Recognizing psychiatric
symptoms during detention. J Forensic Leg Med. 2012;19(6):332–6.
17. Wohl DA, Golin C, Rosen DL, May JM, White BL. Detection of undiagnosed
HIV among state prison entrants. JAMA. 2013;310(20):2198–9.
18. Jurgens R, Nowak M, Day M. HIV and incarceration: prisons and
detention. J Int AIDS Soc. 2011;14:26.
19. Dumont DM, Brockmann B, Dickman S, Alexander N, Rich JD. Public
health and the epidemic of incarceration. Annu Rev Public Health.
2012;33:325–39.
20. Semaille C, Le Strat Y, Chiron E, Chemlal K, Valantin MA, Serre P, et al.
Prevalence of human immunodeficiency virus and hepatitis C virus among
French prison inmates in 2010: a challenge for public health policy. Euro
Surveill. 2013;18(28). doi:10.2807/1560-7917.ES2013.18.28.20524.
21. Iten A, Gravier B, Brenner E, Khelifa A, Beer D, Duflon JP. Epidémiologie et
prévention des infections dans les prisons de Suisse romande (EPIPS):
deuxième phase de l'étude: rapport final, 1er novembre 2001-30 novembre
2005. Fonds national suisse de la recherche scientifique (FNS), Service de
médecine et de psychiatrie pénitentiaires du canton de Vaud, Département
de psychiatrie du CHUV, Lausanne, (3346-64170) 322 p., 2005. https://
serval.unil.ch/resource/serval:BIB_2951CD93FE79.P001/REF. Accessed
September 2015.
22. Wilper AP, Woolhandler S, Boyd JW, Lasser KE, McCormick D, Bor DH, et al.
The health and health care of US prisoners: results of a nationwide survey.
Am J Public Health. 2009;99(4):666–72.
23. Walmsley R. World female imprisonment list. London: International centre
for prison Studies; 2006.
24. Walmsley R. World prison population list. 2nd ed. London: Home Office
Research, Development and Statistics Director-ate, 2000; 2000.
25. Williams BA, Goodwin JS, Baillargeon J, Ahalt C, Walter LC. Addressing the
aging crisis in U.S. criminal justice health care. J Am Geriatr Soc.
2012;60(6):1150–6.
26. Hayes AJ, Burns A, Turnbull P, Shaw JJ. The health and social needs of older
male prisoners. Int J Geriatr Psychiatry. 2012;27(11):1155–62.
27. Dawes J. Ageing Prisoners: issues for Social work. Aust Soc Work.
2009;62(2):258–71.
28. Loeb SJ, Abudagga A. Health-related research on older inmates: an
integrative review. Res Nurs Health. 2006;29(6):556–65.
29. Williams BA, Stern MF, Mellow J, Safer M, Greifinger RB. Aging in correctional
custody: setting a policy agenda for older prisoner health care. Am J Public
Health. 2012;102(8):1475–81.
30. Macdonald M. Women prisoners, mental health, violence and abuse. Int J
Law Psychiatry. 2013;36(3-4):293–303.
31. van den Bergh BJ, Gatherer A, Fraser A, Moller L. Imprisonment and
women’s health: concerns about gender sensitivity, human rights and
public health. Bull World Health Organ. 2011;89(9):689–94.
32. World Health Organization WHO. Health in Prisons, A WHO guide to the
essentials in prison health. 2007.
33. Swiss Federal Statistical Office FSO. Privation de liberté, l'effectif de détenus
au jour de relevé 1999-2013. 2014.
34. Dauvergne M. Adult correctional statistics in Canada, 2010/2011.
Statistics Canada. 2012. access website september 2015: http://
www.statcan.gc.ca/pub/85-002-x/2012001/article/11715-eng.htm
35. Académies Suisses des Sciences Médicales A. Exercice de la médecine
auprès de personnes détenues - SAMW. Rapport des Académies Suisses des
Sciences médicales 2002, updated 2012. http://www.samw.ch/fr/Ethique/
Exercice-de-la-medecine-carcerale.html. Accessed September 2015.
36. Sprumont D, Schaffter G, Hostettler U, Richter M, Perrenoud J.
Pratiques medicales de la médecine en milieu carcéral: Effectivité des
directives de l’Académie suisse des sciences médiclaes sur l’exercice
de la médecine aupres de personnes détenues. Document de travail,
Université de Neuchatel, Faculté de droit, Institut de droit de la
santé. 2009. www.unine.ch/ids/. Accessed August 2015.
37. World Health Organization WHO. International Classification of Diseases
(ICD). 2014.
38. Carpentier C. Ten years of monitoring illicit drug use in prison population in
Europe: issues and challenges. The Howard Journal of Crininal justice.
2011;51(1):37–66.
39. Gravier B, Benmebarek M. Enfermement et addictions : quelle place pour les
soins? Dépendances. 2008;35:11-15.
40. Torrens M, Fonseca F, Castillo C, Domingo-Salvany A. Methadone
maintenance treatment in Spain: the success of a harm reduction
approach, Bulletin of the World Health Organization 2013;91:136-141.
Bull World Health Organ. 2013;91:136–41.
41. Réseau canadien d’info-traitements sida C. Le VIH au canada Tendnaces et
enjeux qui affectent la prevention du VIH, les soins le traitement et le
soutien. 2010.
42. Réseau juridique canadien VIH/sida; Redoubler d’efforts contre le sida et
pour les droits humains. 2010;15(1). www.aidslaw.ca/revue. Accessed
September 2015.
43. World Health Organization WHO. The global plan to stop TB 2006-2015. 2006.
44. Fazel S, Hope T, O’Donnell I, Jacoby R. Hidden psychiatric morbidity in
elderly prisoners. Br J Psychiatry. 2001;179:535–9.
45. Fazel S, Hope T, O’Donnell I, Piper M, Jacoby R. Health of elderly male
prisoners: worse than the general population, worse than younger
prisoners. Age Ageing. 2001;30(5):403–7.
46. World Health Organization UNODC:. Good governance for prison
health in the 21st century. A policy brief on the organization of prison
health. 2013.
47. Maschi T, Kwak J, Ko E, Morrissey MB. Forget me not: dementia in prison.
Gerontologist. 2012;52(4):441–51.
48. Turner M, Payne S, Barbarachild Z. Care or custody? An evaluation of
palliative care in prisons in North West England. Palliat Med.
2011;25(4):370–7.
49. Zurhold H, Stöver H, Haasen C. Female drug users in European prisons —
Best practice for relapse prevention and reintegration. Hamburg: Centre for
Interdisciplinary Addiction Research, University of Hamburg; 2004.
50. World Health Organization UNODC. Women’s health in prison, Correcting
gender inequity in prison health. 2009.
51. Rowan-Szal GA, Joe GW, Bartholomew NG, Pankow J, Simpson DD. Brief
trauma and mental health assessments for female offenders in addiction
treatment. J Offender Rehabil. 2012;51(1-2):57–77.
52. Newma WJ, Scott CL. Brown v. Plata: Overcrowding in California’s
prisons. J Am Acad Psychiatry Law. 2012;40:547–52.
53. Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH.
Treatment of medical, psychiatric, and substance-use comorbidities in
people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.
54. World Health Organization WHO. Mental Health in Prisons, Headquarters
and the International Committee of the Red Cross. 2005. Information Sheet.
55. Swiss Federal Statistical Office FS. Privation de liberté et exécution des
sanctions - Données, indicateurs. 2013.
56. Swiss Federal Statistical Office FSO. Survol des maladies infectieuses. 2011.
57. Negro F. La lutte contre l’hépatite B et C est une urgence pour la santé
publique en Suisse. Bulletin des médecins suisses. 2013;94(27):1073-74.
58. Swiss Federal Statistical Office FSO. Prévalences de troubles physiques
importants. 2011.
59. Swiss Health Observatory OBSAN. Rapport de base sur la santé pour le
canton de Vaud. 2014. Dossier 40.
60. Bridevaux PO, Probst-Hensch NM, Schindler C, Curjuric I, Felber Dietrich D,
Braendli O, et al. Prevalence of airflow obstruction in smokers and never-
smokers in Switzerland. Eur Respir J. 2010;36(6):1259–69.
61. Swiss Health Observatory OBSAN. La santé dans le canton de Vaud,
Analyse des données de l’Enquête suisse sur la santé 2007. 2011.
OBSAN RAPPORT 46.
Moschetti et al. BMC Public Health  (2015) 15:872 Page 11 of 11
